BioArctic Future Growth
Future criteria checks 6/6
BioArctic is forecast to grow earnings and revenue by 98.4% and 42.4% per annum respectively. EPS is expected to grow by 55.8% per annum. Return on equity is forecast to be 27.9% in 3 years.
Key information
98.4%
Earnings growth rate
55.8%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 42.4% |
| Future return on equity | 27.9% |
| Analyst coverage | Good |
| Last updated | 02 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,550 | 531 | 677 | 704 | 5 |
| 12/31/2025 | 895 | 255 | 351 | 294 | 6 |
| 12/31/2024 | 273 | -221 | -317 | -307 | 4 |
| 6/30/2024 | 299 | -88 | -142 | -134 | N/A |
| 3/31/2024 | 252 | -122 | -111 | -104 | N/A |
| 12/31/2023 | 616 | 229 | 302 | 310 | N/A |
| 9/30/2023 | 607 | 259 | 111 | 124 | N/A |
| 6/30/2023 | 617 | 270 | 284 | 289 | N/A |
| 3/31/2023 | 619 | 327 | 294 | 307 | N/A |
| 12/31/2022 | 229 | -11 | -44 | -32 | N/A |
| 9/30/2022 | 232 | 28 | -15 | -13 | N/A |
| 6/30/2022 | 18 | -147 | -170 | -159 | N/A |
| 3/31/2022 | 21 | -135 | -147 | -143 | N/A |
| 12/31/2021 | 26 | -120 | -145 | -140 | N/A |
| 9/30/2021 | 30 | -114 | -138 | -128 | N/A |
| 6/30/2021 | 37 | -97 | -114 | -103 | N/A |
| 3/31/2021 | 34 | -101 | -106 | -93 | N/A |
| 12/31/2020 | 65 | -69 | -105 | -92 | N/A |
| 9/30/2020 | 84 | -72 | -125 | -120 | N/A |
| 6/30/2020 | 93 | -60 | -163 | -160 | N/A |
| 3/31/2020 | 252 | 78 | -46 | -43 | N/A |
| 12/31/2019 | 283 | 88 | 324 | 327 | N/A |
| 9/30/2019 | 779 | 441 | 286 | 292 | N/A |
| 6/30/2019 | 852 | 475 | 305 | 310 | N/A |
| 3/31/2019 | 729 | 380 | 171 | 176 | N/A |
| 12/31/2018 | 722 | 382 | -204 | -200 | N/A |
| 9/30/2018 | 257 | 58 | -161 | -157 | N/A |
| 6/30/2018 | 197 | 32 | -152 | -149 | N/A |
| 3/31/2018 | 194 | 29 | N/A | -139 | N/A |
| 12/31/2017 | 157 | 15 | N/A | -135 | N/A |
| 9/30/2017 | 193 | 78 | N/A | 616 | N/A |
| 6/30/2017 | 160 | 71 | N/A | 630 | N/A |
| 3/31/2017 | 127 | 64 | N/A | 647 | N/A |
| 12/31/2016 | 106 | 58 | N/A | 675 | N/A |
| 12/31/2015 | 42 | 4 | N/A | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BRCT.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: BRCT.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BRCT.F is expected to become profitable in the next 3 years.
Revenue vs Market: BRCT.F's revenue (42.4% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: BRCT.F's revenue (42.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BRCT.F's Return on Equity is forecast to be high in 3 years time (27.9%)